Picture of Hi-Great Holding Co logo

HIGR Hi-Great Holding Co Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-98.25%
3m-98.27%
6m-98.39%
1yr-98.51%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-109.89%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Hi-Great Holding Co EPS forecast chart

Profile Summary

Hi-Great Group Holding Company is a development stage company. The Company focuses on the distribution of plant-based finished consumer products and integrating the use of specialty herbs into its worldwide health supplement business to include expansion into the cosmetics sector using multiple herbal oils and compounds. It plans to grow organically through Internet sales of its worldwide exclusive license agreement with SellaCare, Inc. in the areas of longevity health supplements and plans to integrate new product lines containing cannabidiol (CBD) oils for additional health benefits and also expand into the cosmetic sector.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    March 31st, 2024
    Incorporated
    September 21st, 2010
    Public Since
    February 16th, 2011
    No. of Shareholders
    69
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    100,000,000
    Blurred out image of a map
    Address
    621 S. Virgil Ave #470, LOS ANGELES, 90005
    Web
    Phone
    +1 2132197746
    Auditors
    M. N. Vijay Kumar

    HIGR Share Price Performance

    Similar to HIGR

    Picture of Acorda Therapeutics logo

    Acorda Therapeutics

    us flag iconPink Sheets on Nasdaq

    Picture of Actavia Life Sciences logo

    Actavia Life Sciences

    us flag iconPink Sheets on Nasdaq

    Picture of Acura Pharmaceuticals logo

    Acura Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    Picture of Adhera Therapeutics logo

    Adhera Therapeutics

    us flag iconPink Sheets on Nasdaq

    Picture of Ramoil Management logo

    Ramoil Management

    us flag iconPink Sheets on Nasdaq

    FAQ